Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Breast Cancer

  Free Subscription


13.03.2017

6 AJR Am J Roentgenol
2 Ann Surg
2 BMC Cancer
2 Breast Cancer
5 Breast Cancer Res
8 Breast Cancer Res Treat
5 Cancer
1 Cancer Epidemiol Biomarkers Prev
2 Cancer Lett
2 Clin Cancer Res
3 Eur J Cancer
2 Eur J Surg Oncol
1 Gene
1 Histopathology
4 Int J Cancer
1 Int J Oncol
1 J Biol Chem
1 Oncogene
4 Oncol Rep
1 PLoS Genet
2 PLoS One
2 Proc Natl Acad Sci U S A


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AJR Am J Roentgenol

  1. DESTOUNIS S, Johnston L, Highnam R, Arieno A, et al
    Using Volumetric Breast Density to Quantify the Potential Masking Risk of Mammographic Density.
    AJR Am J Roentgenol. 2016.
    PubMed     Text format     Abstract available

  2. GRABLER P, Sighoko D, Wang L, Allgood K, et al
    Recall and Cancer Detection Rates for Screening Mammography: Finding the Sweet Spot.
    AJR Am J Roentgenol. 2016.
    PubMed     Text format     Abstract available

  3. SHIN K, Caudle AS, Kuerer HM, Santiago L, et al
    Radiologic Mapping for Targeted Axillary Dissection: Needle Biopsy to Excision.
    AJR Am J Roentgenol. 2016.
    PubMed     Text format     Abstract available

  4. HRUSKA CB
    Molecular Breast Imaging for Screening in Dense Breasts: State of the Art and Future Directions.
    AJR Am J Roentgenol. 2016.
    PubMed     Text format     Abstract available

  5. LEWIN AA, Heller SL, Jaglan S, Elias K, et al
    Radiologic-Pathologic Discordance and Outcome After MRI-Guided Vacuum-Assisted Biopsy.
    AJR Am J Roentgenol. 2016.
    PubMed     Text format     Abstract available

  6. PRABHU V, Chhor CM, Ego-Osuala IO, Xiao JM, et al
    Frequency and Outcomes of Incidental Breast Lesions Detected on Abdominal MRI Over a 7-Year Period.
    AJR Am J Roentgenol. 2016.
    PubMed     Text format     Abstract available


    Ann Surg

  7. SPOLVERATO G, Vitale A, Bagante F, Connolly R, et al
    Liver Resection for Breast Cancer Liver Metastases: A Cost-utility Analysis.
    Ann Surg. 2017;265:792-799.
    PubMed     Text format     Abstract available

  8. LANGHANS L, Tvedskov TF, Klausen TL, Jensen MB, et al
    Radioactive Seed Localization or Wire-guided Localization of Nonpalpable Invasive and In Situ Breast Cancer: A Randomized, Multicenter, Open-label Trial.
    Ann Surg. 2017 Mar 2. doi: 10.1097/SLA.0000000000002101.
    PubMed     Text format     Abstract available


    BMC Cancer

  9. KROZ M, Reif M, Glinz A, Berger B, et al
    Impact of a combined multimodal-aerobic and multimodal intervention compared to standard aerobic treatment in breast cancer survivors with chronic cancer-related fatigue - results of a three-armed pragmatic trial in a comprehensive cohort design.
    BMC Cancer. 2017;17:166.
    PubMed     Text format     Abstract available

  10. CHARAGHVANDI RK, van Asselen B, Philippens ME, Verkooijen HM, et al
    Redefining radiotherapy for early-stage breast cancer with single dose ablative treatment: a study protocol.
    BMC Cancer. 2017;17:181.
    PubMed     Text format     Abstract available


    Breast Cancer

  11. GALLI G, Tessari A, Di Cosimo S
    Disease-free interval in metastatic breast cancer patients undergoing complete remission: implications of cross-sectional study design and biologic considerations about disease history.
    Breast Cancer. 2017 Mar 6. doi: 10.1007/s12282-017-0766.
    PubMed     Text format    

  12. ALTUNDAG K
    Robust predictive markers are needed for early detection of trastuzumab-related cardiac dysfunction in breast cancer.
    Breast Cancer. 2017 Mar 8. doi: 10.1007/s12282-017-0767.
    PubMed     Text format    


    Breast Cancer Res

  13. BECA F, Kensler K, Glass B, Schnitt SJ, et al
    EZH2 protein expression in normal breast epithelium and risk of breast cancer: results from the Nurses' Health Studies.
    Breast Cancer Res. 2017;19:21.
    PubMed     Text format     Abstract available

  14. SHACKSHAFT L, Van Hemelrijck M, Garmo H, Malmstrom H, et al
    Circulating gamma-glutamyl transferase and development of specific breast cancer subtypes: findings from the Apolipoprotein Mortality Risk (AMORIS) cohort.
    Breast Cancer Res. 2017;19:22.
    PubMed     Text format     Abstract available

  15. BUEHRING GC
    Response to "Lack of association between bovine leukemia virus and breast cancer in Chinese patients".
    Breast Cancer Res. 2017;19:24.
    PubMed     Text format    

  16. XIONG J, Li J, Yang Q, Wang J, et al
    Gossypol has anti-cancer effects by dual-targeting MDM2 and VEGF in human breast cancer.
    Breast Cancer Res. 2017;19:27.
    PubMed     Text format     Abstract available

  17. LEMLER DJ, Lynch ML, Tesfay L, Deng Z, et al
    DCYTB is a predictor of outcome in breast cancer that functions via iron-independent mechanisms.
    Breast Cancer Res. 2017;19:25.
    PubMed     Text format     Abstract available


    Breast Cancer Res Treat

  18. ENGSTROM MJ, Valla M, Bofin AM
    Basal markers and prognosis in luminal breast cancer.
    Breast Cancer Res Treat. 2017 Mar 3. doi: 10.1007/s10549-017-4182.
    PubMed     Text format     Abstract available

  19. RUGO HS, Melin SA, Voigt J
    Scalp cooling with adjuvant/neoadjuvant chemotherapy for breast cancer and the risk of scalp metastases: systematic review and meta-analysis.
    Breast Cancer Res Treat. 2017 Mar 8. doi: 10.1007/s10549-017-4185.
    PubMed     Text format     Abstract available

  20. CAMPANA LG, Galuppo S, Valpione S
    Treatment of cutaneous metastases of breast cancer with electrochemotherapy: what is the magnitude of clinical benefit?
    Breast Cancer Res Treat. 2017 Mar 8. doi: 10.1007/s10549-017-4186.
    PubMed     Text format    

  21. CONWAY K, Edmiston SN, Parrish E, Bryant C, et al
    Breast tumor DNA methylation patterns associated with smoking in the Carolina Breast Cancer Study.
    Breast Cancer Res Treat. 2017 Mar 8. doi: 10.1007/s10549-017-4178.
    PubMed     Text format     Abstract available

  22. VADAPARAMPIL ST, Christie J, Donovan KA, Kim J, et al
    Health-related quality of life in Black breast cancer survivors with and without triple-negative breast cancer (TNBC).
    Breast Cancer Res Treat. 2017 Mar 3. doi: 10.1007/s10549-017-4173.
    PubMed     Text format     Abstract available

  23. BINGHAM C, Fernandez SV, Fittipaldi P, Dempsey PW, et al
    Mutational studies on single circulating tumor cells isolated from the blood of inflammatory breast cancer patients.
    Breast Cancer Res Treat. 2017 Mar 7. doi: 10.1007/s10549-017-4176.
    PubMed     Text format     Abstract available

  24. CORNELISSEN AJ, Kool M, Lopez Penha TR, Keuter XH, et al
    Lymphatico-venous anastomosis as treatment for breast cancer-related lymphedema: a prospective study on quality of life.
    Breast Cancer Res Treat. 2017 Mar 7. doi: 10.1007/s10549-017-4180.
    PubMed     Text format     Abstract available

  25. LEOPOLD RB, Thomas AW, Concannon KF, Correll AD, et al
    Breast cancer screening in patients with cancers other than breast.
    Breast Cancer Res Treat. 2017 Mar 6. doi: 10.1007/s10549-017-4179.
    PubMed     Text format     Abstract available


    Cancer

  26. LUCAS AR, Levine BJ, Avis NE
    Posttreatment trajectories of physical activity in breast cancer survivors.
    Cancer. 2017 Mar 8. doi: 10.1002/cncr.30641.
    PubMed     Text format     Abstract available

  27. FU J, Wu L, Jiang M, Li D, et al
    Real-world impact of non-breast cancer-specific death on overall survival in resectable breast cancer.
    Cancer. 2017 Mar 7. doi: 10.1002/cncr.30617.
    PubMed     Text format     Abstract available

  28. PRINTZ C
    Genomic sequencing of treatment-resistant metastatic breast cancer reveals key alterations.
    Cancer. 2017;123:904.
    PubMed     Text format    

  29. KUCUK O
    Soy foods, isoflavones, and breast cancer.
    Cancer. 2017 Mar 6. doi: 10.1002/cncr.30614.
    PubMed     Text format    

  30. ZHANG FF, Haslam DE, Terry MB, Knight JA, et al
    Dietary isoflavone intake and all-cause mortality in breast cancer survivors: The Breast Cancer Family Registry.
    Cancer. 2017 Mar 6. doi: 10.1002/cncr.30615.
    PubMed     Text format     Abstract available


    Cancer Epidemiol Biomarkers Prev

  31. JANKOWSKA MM, Natarajan L, Godbole S, Meseck K, et al
    Kernel Density Estimation as a Measure of Environmental Exposure Related to Insulin Resistance in Breast Cancer Survivors.
    Cancer Epidemiol Biomarkers Prev. 2017 Mar 3. pii: cebp.0927.2016.
    PubMed     Text format     Abstract available


    Cancer Lett

  32. BURNETT JP, Lim G, Li Y, Shah RB, et al
    Sulforaphane enhances the anticancer activity of taxanes against triple negative breast cancer by killing cancer stem cells.
    Cancer Lett. 2017 Feb 27. pii: S0304-3835(17)30132.
    PubMed     Text format     Abstract available

  33. LI Y, Li J, Zhang Y, Wang Y, et al
    Roles of Cancer/Testis Antigens (CTAs) in Breast Cancer.
    Cancer Lett. 2017 Mar 5. pii: S0304-3835(17)30148.
    PubMed     Text format     Abstract available


    Clin Cancer Res

  34. MA CX, Gao F, Luo J, Northfelt DW, et al
    NeoPalAna: Neoadjuvant palbociclib, a cyclin-dependent kinase 4/6 inhibitor, and anastrozole for clinical stage 2 or 3 estrogen receptor positive breast cancer.
    Clin Cancer Res. 2017 Mar 7. pii: clincanres.3206.2016.
    PubMed     Text format     Abstract available

  35. JOVANOVIC B, Mayer IA, Mayer EL, Abramson VG, et al
    A randomized phase II neoadjuvant study of cisplatin, paclitaxel with or without everolimus in patients with stage II/III triple-negative breast cancer (TNBC).
    Clin Cancer Res. 2017 Mar 7. pii: clincanres.3055.2016.
    PubMed     Text format     Abstract available


    Eur J Cancer

  36. DUFFY MJ, Harbeck N, Nap M, Molina R, et al
    Clinical use of biomarkers in breast cancer: Updated guidelines from the European Group on Tumor Markers (EGTM).
    Eur J Cancer. 2017;75:284-298.
    PubMed     Text format     Abstract available

  37. RIET FG, Fayard F, Arriagada R, Santos MA, et al
    Preoperative radiotherapy in breast cancer patients: 32 years of follow-up.
    Eur J Cancer. 2017;76:45-51.
    PubMed     Text format     Abstract available

  38. AMBATIPUDI S, Horvath S, Perrier F, Cuenin C, et al
    DNA methylome analysis identifies accelerated epigenetic ageing associated with postmenopausal breast cancer susceptibility.
    Eur J Cancer. 2017;75:299-307.
    PubMed     Text format     Abstract available


    Eur J Surg Oncol

  39. MEATTINI I, Francolini G, Livi L, Nori J, et al
    In reply to: Anti-HER2 neoadjuvant treatment may have an impact on discordance between preoperative core needle biopsy and surgical specimen in early breast cancer.
    Eur J Surg Oncol. 2017 Feb 21. pii: S0748-7983(17)30352.
    PubMed     Text format    

  40. HAMELINCK VC, Stiggelbout AM, van de Velde CJ, Liefers GJ, et al
    Treatment recommendations for older women with breast cancer: A survey among surgical, radiation and medical oncologists.
    Eur J Surg Oncol. 2017 Feb 20. pii: S0748-7983(17)30351.
    PubMed     Text format     Abstract available


    Gene

  41. MAURO JA, Yavorski JM, Blanck G
    Stratifying melanoma and breast cancer TCGA datasets on the basis of the CNV of transcription factor binding sites common to proliferation- and apoptosis-effector genes.
    Gene. 2017 Feb 28. pii: S0378-1119(17)30126-9. doi: 10.1016/j.gene.2017.
    PubMed     Text format     Abstract available


    Histopathology

  42. POLONIA A, Eloy C, Pinto J, Braga AC, et al
    Counting invasive breast cancer cells in HER2 silver in situ hybridization test: how many cells are enough?
    Histopathology. 2017 Mar 7. doi: 10.1111/his.13208.
    PubMed     Text format     Abstract available


    Int J Cancer

  43. WANG J, Shidfar A, Ivancic D, Ranjan M, et al
    Overexpression of lipid metabolism genes and PBX1 in the contralateral breasts of women with estrogen receptor-negative breast cancer.
    Int J Cancer. 2017 Mar 6. doi: 10.1002/ijc.30680.
    PubMed     Text format     Abstract available

  44. PARK YM, White AJ, Nichols HB, O'Brien KM, et al
    The association between metabolic health, obesity phenotype and the risk of breast cancer.
    Int J Cancer. 2017 Mar 7. doi: 10.1002/ijc.30684.
    PubMed     Text format     Abstract available

  45. VAN DEN BRANDT PA, Schulpen M
    Mediterranean diet adherence and risk of postmenopausal breast cancer: results of a cohort study and meta-analysis.
    Int J Cancer. 2017 Mar 5. doi: 10.1002/ijc.30654.
    PubMed     Text format     Abstract available

  46. GADEYNE S, Menvielle G, Kulhanova I, Bopp M, et al
    The turn of the gradient? Educational differences in breast cancer mortality in 18 European populations during the 2000s.
    Int J Cancer. 2017 Mar 7. doi: 10.1002/ijc.30685.
    PubMed     Text format     Abstract available


    Int J Oncol

  47. PANAGOPOULOS V, Leach DA, Zinonos I, Ponomarev V, et al
    Inflammatory peroxidases promote breast cancer progression in mice via regulation of the tumour microenvironment.
    Int J Oncol. 2017 Feb 20. doi: 10.3892/ijo.2017.3883.
    PubMed     Text format     Abstract available


    J Biol Chem

  48. YAMAGUCHI N, Nakayama Y, Yamaguchi N
    Down-regulation of Forkhead Box Protein A1 (FOXA1) Leads to Cancer-stem Cell-like Properties in Tamoxifen-resistant Breast Cancer Cells through Induction of Interleukin-6.
    J Biol Chem. 2017 Mar 7. pii: jbc.M116.763276. doi: 10.1074/jbc.M116.763276.
    PubMed     Text format     Abstract available


    Oncogene

  49. YU L, Di Y, Xin L, Ren Y, et al
    SND1 acts as a novel gene transcription activator recognizing the conserved Motif domains of Smad promoters, inducing TGFbeta1 response and breast cancer metastasis.
    Oncogene. 2017 Mar 6. doi: 10.1038/onc.2017.
    PubMed     Text format     Abstract available


    Oncol Rep

  50. GRIFFITH J, Andrade D, Mehta M, Berry W, et al
    Silencing BMI1 radiosensitizes human breast cancer cells by inducing DNA damage and autophagy.
    Oncol Rep. 2017 Feb 28. doi: 10.3892/or.2017.5478.
    PubMed     Text format     Abstract available

  51. HUTH HW, Santos DM, Gravina HD, Resende JM, et al
    Upregulation of p38 pathway accelerates proliferation and migration of MDA-MB-231 breast cancer cells.
    Oncol Rep. 2017 Feb 14. doi: 10.3892/or.2017.5452.
    PubMed     Text format     Abstract available

  52. LUO P, Lu G, Fan LL, Zhong X, et al
    Dysregulation of TMPRSS3 and TNFRSF11B correlates with tumorigenesis and poor prognosis in patients with breast cancer.
    Oncol Rep. 2017 Feb 14. doi: 10.3892/or.2017.5449.
    PubMed     Text format     Abstract available

  53. WU CW, Liu HC, Yu YL, Hung YT, et al
    Combined treatment with vitamin C and methotrexate inhibits triple-negative breast cancer cell growth by increasing H2O2 accumulation and activating caspase-3 and p38 pathways.
    Oncol Rep. 2017 Feb 10. doi: 10.3892/or.2017.5439.
    PubMed     Text format     Abstract available


    PLoS Genet

  54. STRICKER TP, Brown CD, Bandlamudi C, McNerney M, et al
    Robust stratification of breast cancer subtypes using differential patterns of transcript isoform expression.
    PLoS Genet. 2017;13:e1006589.
    PubMed     Text format     Abstract available


    PLoS One

  55. SON SH, Choi KH, Kim SW
    Dosimetric comparison of simultaneous integrated boost with whole-breast irradiation for early breast cancer.
    PLoS One. 2017;12:e0173552.
    PubMed     Text format     Abstract available

  56. MENNING S, de Ruiter MB, Veltman DJ, Boogerd W, et al
    Changes in brain activation in breast cancer patients depend on cognitive domain and treatment type.
    PLoS One. 2017;12:e0171724.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  57. SHAHI P, Wang CY, Lawson DA, Slorach EM, et al
    ZNF503/Zpo2 drives aggressive breast cancer progression by down-regulation of GATA3 expression.
    Proc Natl Acad Sci U S A. 2017 Mar 3. pii: 201701690.
    PubMed     Text format     Abstract available

  58. CHEN IH, Xue L, Hsu CC, Paez JS, et al
    Phosphoproteins in extracellular vesicles as candidate markers for breast cancer.
    Proc Natl Acad Sci U S A. 2017 Mar 7. pii: 201618088.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: